Articles Related to pharmacokinetic studies
Pharmacy Compounding Quality Control and Pharmaceutical Development Strategies for Seventeen alpha Hydroxyprogesterone Caproate in Prevention of Preterm Delivery
Seventeen alpha hydroxyprogesterone caproate (17-OHPC) is the only FDA-approved drug labeled for prevention of preterm delivery. This drug is also available as a compounded product from licensed compounding pharmacies. This article reviews the FDA approval history and pharmacy compounding quality control data of 17-OHPC, as well as briefly discusses possible future pharmaceutical development strategies for 17-OHPC.
Editorial Board Members Related to pharmacokinetic studies
Kit-Lam Chan
Professor
School of Pharmaceutical Sciences
Universiti Sains Malaysia
Malaysia
School of Pharmaceutical Sciences
Universiti Sains Malaysia
Malaysia
Nashiru Billa
Associate professor
Faculty of Science
University of Nottingham
Malaysia
Faculty of Science
University of Nottingham
Malaysia